Clinical Trial

A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency Syndrome

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a single-center, randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy and safety of L-fucose supplementation in subjects with GLUT1 deficiency syndrome (GLUT1DS).
Protocol Amendment History 2 changes
critical Recruitment opened 2026-05-14
notable Primary completion pushed: 2027-05 -> 2027-07 2026-05-14
Trial Details
NCT Number NCT07432490
Lead Sponsor Oregon Health and Science University
Collaborators: Glut1 Deficiency Foundation
Conditions Glut1 Deficiency, GLUT1DS1
Enrollment 16 participants
Start Date 2026-05-05
Primary Completion 2027-07 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-05-13